Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

183
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
183
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

219
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
219
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

408
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
408
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

205
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
205
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

174
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
174
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

370
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
370

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulant treatment for subsegmental pulmonary embolism.

The Cochrane database of systematic reviews·2016
Same author

Outpatient versus inpatient treatment for acute pulmonary embolism.

The Cochrane database of systematic reviews·2014
Same author

Anticoagulant treatment for subsegmental pulmonary embolism.

The Cochrane database of systematic reviews·2014
See all related articles

Related Experiment Video

Updated: Dec 21, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

706

Isolated subsegmental pulmonary embolism: current therapeutic challenges.

Hugo H B Yoo1, Flávia L Marin2

  • 1Department of Internal Medicine, Botucatu Medical School, São Paulo State University (UNESP), São Paulo, Brazil. hugo.yoo@unesp.br

Polish Archives of Internal Medicine
|May 20, 2020
PubMed
Summary

Subsegmental pulmonary embolism (SSPE) is increasingly diagnosed but its clinical significance is unclear. This review explores the therapeutic challenges and controversies surrounding SSPE and isolated SSPE (ISSPE) management.

More Related Videos

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

666
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

430

Related Experiment Videos

Last Updated: Dec 21, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

706
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

666
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

430

Area of Science:

  • Pulmonary vascular disease
  • Diagnostic imaging
  • Clinical decision-making

Background:

  • Computed tomography pulmonary angiography (CTPA) has improved visualization of peripheral pulmonary vessels, leading to increased detection of subsegmental pulmonary embolism (SSPE).
  • Despite increased SSPE diagnoses, mortality rates have not significantly changed, raising questions about the clinical relevance of these findings.
  • The clinical significance of SSPE, particularly isolated SSPE (ISSPE), remains poorly understood, creating diagnostic and therapeutic uncertainty.

Purpose of the Study:

  • To review the current understanding of SSPE and ISSPE.
  • To address the diagnostic and therapeutic controversies surrounding these conditions.
  • To provide insights into the clinical relevance and management of small pulmonary emboli.

Main Methods:

  • Literature review of studies investigating SSPE and ISSPE.
  • Analysis of clinical presentation and outcomes associated with SSPE and ISSPE.
  • Discussion of current therapeutic guidelines and dilemmas.

Main Results:

  • SSPE is often found in patients with low clinical probability of pulmonary embolism (PE), frequently presenting with chest pain or asymptomatic.
  • Central PE typically presents with dyspnea, suggesting a potential difference in clinical severity compared to SSPE.
  • Limited data exist to guide the management of ISSPE, leading to therapeutic dilemmas regarding anticoagulation.

Conclusions:

  • The clinical significance of SSPE and ISSPE requires further investigation.
  • A therapeutic dilemma exists regarding the necessity of anticoagulation for all patients with small PE.
  • Further research is needed to establish evidence-based guidelines for managing SSPE and ISSPE.